Ketamine Therapy in Illinois

Ketamine therapy in Illinois is governed by a combination of federal drug scheduling regulations and state-level medical practice standards. At the federal level, ketamine is classified as a Schedule III controlled substance under the Controlled Substances Act, meaning that any provider administering ketamine must hold a valid DEA registration. In Illinois, physicians, advanced practice registered nurses (APRNs), and other licensed prescribers who administer or prescribe ketamine must comply with the Illinois Controlled Substances Act (720 ILCS 570), which mirrors federal scheduling requirements and establishes state-level oversight for the prescribing, dispensing, and administration of controlled substances.

Ketamine clinics operating in Illinois are subject to licensing and oversight through the Illinois Department of Financial and Professional Regulation (IDFPR), which governs the licensure of healthcare professionals including physicians, APRNs, and physician assistants. Clinics providing intravenous (IV) ketamine infusions are typically required to operate within a medical facility setting under the supervision of a licensed physician, most commonly an anesthesiologist, psychiatrist, or other appropriately trained specialist. The Illinois Department of Public Health (IDPH) may also have jurisdiction over certain facility requirements depending on the scope of services offered. Providers must maintain detailed records of controlled substance administration in compliance with both state and federal requirements.

While ketamine has received FDA approval as an anesthetic, its use for psychiatric conditions such as treatment-resistant depression, anxiety, PTSD, and chronic pain is largely considered off-label, meaning clinics are not subject to a specific state-mandated treatment protocol for these applications. However, practitioners are expected to adhere to prevailing standards of care and informed consent requirements as established by their respective licensing boards. The American Society of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3) and similar professional organizations provide voluntary clinical guidelines that many Illinois providers follow to ensure patient safety and ethical practice.

Patients seeking ketamine therapy in Illinois should be aware of several important considerations when evaluating providers:

• Confirming that the administering provider holds an active Illinois medical license and valid DEA registration
• Verifying that the clinic conducts thorough medical and psychiatric evaluations prior to treatment
• Ensuring that informed consent documentation clearly outlines the off-label nature of the treatment, potential risks, and expected outcomes
• Confirming that appropriate emergency equipment and protocols are in place, particularly for IV infusion settings
• Understanding that ketamine therapy is generally not covered by insurance for psychiatric indications, and that out-of-pocket costs can vary significantly between providers